|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 33833 |
FusionGeneSummary for SIAH1_CREBBP |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SIAH1_CREBBP | Fusion gene ID: 33833 | Hgene | Tgene | Gene symbol | SIAH1 | CREBBP | Gene ID | 6477 | 1387 |
| Gene name | siah E3 ubiquitin protein ligase 1 | CREB binding protein | |
| Synonyms | SIAH1A | CBP|KAT3A|RSTS|RSTS1 | |
| Cytomap | 16q12.1 | 16p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | E3 ubiquitin-protein ligase SIAH1RING-type E3 ubiquitin transferase SIAH1seven in absentia homolog 1siah-1a | CREB-binding protein | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q8IUQ4 | Q92793 | |
| Ensembl transtripts involved in fusion gene | ENST00000380006, ENST00000356721, ENST00000394725, ENST00000573005, | ENST00000262367, ENST00000382070, | |
| Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 8 X 17 X 3=408 |
| # samples | 3 | 18 | |
| ** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(18/408*10)=-1.18057224564182 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SIAH1 [Title/Abstract] AND CREBBP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SIAH1 | GO:0006511 | ubiquitin-dependent protein catabolic process | 23001567 |
| Hgene | SIAH1 | GO:0030163 | protein catabolic process | 11389840 |
| Hgene | SIAH1 | GO:0043065 | positive regulation of apoptotic process | 21185211 |
| Tgene | CREBBP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 21539536 |
| Tgene | CREBBP | GO:0006355 | regulation of transcription, DNA-templated | 12169688 |
| Tgene | CREBBP | GO:0006473 | protein acetylation | 15273251|24939902 |
| Tgene | CREBBP | GO:0016573 | histone acetylation | 11742995 |
| Tgene | CREBBP | GO:0018076 | N-terminal peptidyl-lysine acetylation | 12435739 |
| Tgene | CREBBP | GO:0034644 | cellular response to UV | 24939902 |
| Tgene | CREBBP | GO:0045893 | positive regulation of transcription, DNA-templated | 11742995 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BG992160 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000380006 | ENST00000262367 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000380006 | ENST00000382070 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000356721 | ENST00000262367 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000356721 | ENST00000382070 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000394725 | ENST00000262367 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000394725 | ENST00000382070 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000573005 | ENST00000262367 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
| intron-intron | ENST00000573005 | ENST00000382070 | SIAH1 | chr16 | 48454762 | - | CREBBP | chr16 | 3797210 | + |
Top |
FusionProtFeatures for SIAH1_CREBBP |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SIAH1 | CREBBP |
| E3 ubiquitin-protein ligase that mediates ubiquitinationand subsequent proteasomal degradation of target proteins. E3ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directlytransfers the ubiquitin to targeted substrates. Mediates E3ubiquitin ligase activity either through direct binding tosubstrates or by functioning as the essential RING domain subunitof larger E3 complexes. Triggers the ubiquitin-mediateddegradation of many substrates, including proteins involved intranscription regulation (ELL2, MYB, POU2AF1, PML and RBBP8), acell surface receptor (DCC), the cell-surface receptor-typetyrosine kinase FLT3, the cytoplasmic signal transductionmolecules (KLF10/TIEG1 and NUMB), an antiapoptotic protein (BAG1),a microtubule motor protein (KIF22), a protein involved insynaptic vesicle function in neurons (SYP), a structural protein(CTNNB1) and SNCAIP. Confers constitutive instability to HIPK2through proteasomal degradation. It is thereby involved in manycellular processes such as apoptosis, tumor suppression, cellcycle, axon guidance, transcription regulation, spermatogenesisand TNF-alpha signaling. Has some overlapping function with SIAH2.Induces apoptosis in cooperation with PEG3. Upon nitric oxid (NO)generation that follows apoptotic stimulation, interacts with S-nitrosylated GAPDH, mediating the translocation of GAPDH to thenucleus. GAPDH acts as a stabilizer of SIAH1, facilitating thedegradation of nuclear proteins. {ECO:0000269|PubMed:10747903,ECO:0000269|PubMed:11146551, ECO:0000269|PubMed:11389839,ECO:0000269|PubMed:11389840, ECO:0000269|PubMed:11483517,ECO:0000269|PubMed:11483518, ECO:0000269|PubMed:11752454,ECO:0000269|PubMed:12072443, ECO:0000269|PubMed:14506261,ECO:0000269|PubMed:14645235, ECO:0000269|PubMed:14654780,ECO:0000269|PubMed:15064394, ECO:0000269|PubMed:16085652,ECO:0000269|PubMed:18536714, ECO:0000269|PubMed:19224863,ECO:0000269|PubMed:20508617, ECO:0000269|PubMed:22483617,ECO:0000269|PubMed:9334332, ECO:0000269|PubMed:9858595}. | Acetylates histones, giving a specific tag fortranscriptional activation. Also acetylates non-histone proteins,like NCOA3 and FOXO1. Binds specifically to phosphorylated CREBand enhances its transcriptional activity toward cAMP-responsivegenes. Acts as a coactivator of ALX1. Acts as a circadiantranscriptional coactivator which enhances the activity of thecircadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers. Acetylates PCNA; acetylation promotesremoval of chromatin-bound PCNA and its degradation duringnucleotide excision repair (NER) (PubMed:24939902).{ECO:0000269|PubMed:11154691, ECO:0000269|PubMed:12738767,ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221,ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:9707565}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SIAH1_CREBBP |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SIAH1_CREBBP |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SIAH1_CREBBP |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SIAH1_CREBBP |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CREBBP | C0035934 | Rubinstein-Taybi Syndrome | 3 | CTD_human;ORPHANET;UNIPROT |
| Tgene | CREBBP | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| Tgene | CREBBP | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Tgene | CREBBP | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Tgene | CREBBP | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Tgene | CREBBP | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| Tgene | CREBBP | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Tgene | CREBBP | C0011573 | Endogenous depression | 1 | PSYGENET |
| Tgene | CREBBP | C0024301 | Lymphoma, Follicular | 1 | CTD_human |
| Tgene | CREBBP | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | CREBBP | C0036920 | Sezary Syndrome | 1 | CTD_human |
| Tgene | CREBBP | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
| Tgene | CREBBP | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Tgene | CREBBP | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Tgene | CREBBP | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|